Mortality of patients hospitalized for active tuberculosis in King Abdulaziz University Hospital, Jeddah, Saudi Arabia

References

1. ↵
   1. Centers for Disease Control and Prevention

   Tuberculosis: data and statistics-United States, Available at: https://www.cdc.gov/tb/statistics/default.htm. [cited 2016, Accessed 2017 January 9].
2. ↵
   1. World Health Organization

   Global tuberculosis report 2016, Available at: http://www.afro.who.int/sites/default/files/2017-05/9789241565394-eng.pdf. [Accessed 2017 January 9].
3. ↵
   1. Lienhardt C,
   2. Glaziou P,
   3. Uplekar M,
   4. Lonnroth K,
   5. Getahun H,
   6. Raviglione M

   (2012) Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 10:407–416.

   OpenUrlCrossRefPubMed
4. ↵
   1. Glaziou P,
   2. Falzon D,
   3. Floyd K,
   4. Raviglione M

   (2013) Global epidemiology of tuberculosis. Semin Respir Crit Care Med 34:3–16.

   OpenUrlCrossRefPubMed
5. ↵
   1. Lin CH,
   2. Lin CJ,
   3. Kuo YW,
   4. Wang JY,
   5. Hsu CL,
   6. Chen JM,
   7. et al.

   (2014) Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis 14:5.

   OpenUrlCrossRef
6. ↵
   1. Fox GJ,
   2. Barry SE,
   3. Britton WJ,
   4. Marks GB

   (2013) Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 41:140–156.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Dheda K,
   2. Gumbo T,
   3. Gandhi NR,
   4. Murray M,
   5. Theron G,
   6. Udwadia Z,
   7. et al.

   (2014) Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. Lancet Respir Med 2:321–338.

   OpenUrl
8. ↵
   1. Sanchez M,
   2. Bartholomay P,
   3. Arakaki-Sanchez D,
   4. Enarson D,
   5. Bissell K,
   6. Barreira D,
   7. et al.

   (2012) Outcomes of TB treatment by HIV status in National Recording Systems in Brazil 2003-2008. PLoS One 7:e33129.

   OpenUrlCrossRefPubMed
9. ↵
   1. Zhang H,
   2. Huang F,
   3. Chen W,
   4. Du X,
   5. Zhou MG,
   6. Hu J,
   7. et al.

   (2012) Estimates of tuberculosis mortality rates in China using the disease surveillance point system 2004-2010. Biomed Environ Sci 25:483–488.

   OpenUrlPubMed
10. ↵
    1. Duro RP,
    2. Dias PF,
    3. Ferreira AA,
    4. Xerinda SM,
    5. Lima Alves CL,
    6. Sarmento AC,
    7. et al.

    (2017) Severe tuberculosis requiring intensive care: A descriptive analysis. Crit Care Res Pract 2017:1–9.

    OpenUrl
11. ↵
    1. Memish ZA,
    2. Bamgboye EA,
    3. Abuljadayel N,
    4. Smadi H,
    5. Abouzeid MS,
    6. Al Hakeem RF

    (2014) Incidence of and risk factors associated with pulmonary and extra-pulmonary tuberculosis in Saudi Arabia (2010-2011). PLoS One 9:e95654.

    OpenUrl
12. ↵
    1. Lui G,
    2. Wong RYK,
    3. Li F,
    4. Lee MKP,
    5. Lai RWM,
    6. Li TCM,
    7. et al.

    (2014) High mortality in adults hospitalized for active tuberculosis in a low HIV prevalence setting. PLoS One 9:e92077.

    OpenUrlCrossRefPubMed
13. ↵
    1. Kim CW,
    2. Kim SH,
    3. Lee SN,
    4. Lee SJ,
    5. Lee MK,
    6. Lee JH,
    7. et al.

    (2012) Risk factors related with mortality in patient with pulmonary tuberculosis. Tuberc Respir Dis (Seoul) 73:38–47.

    OpenUrl
14. ↵
    1. Shimazaki T,
    2. Marte SD,
    3. Saludar NR,
    4. Dimaano EM,
    5. Salva EP,
    6. Ariyoshi K,
    7. et al.

    (2013) Risk factors for death among hospitalised tuberculosis patients in poor urban areas in Manila, The Philippines. Int J Tuberc Lung Dis 17:1420–1426.

    OpenUrlCrossRefPubMed
15. ↵
    1. Haque G,
    2. Kumar A,
    3. Saifuddin F,
    4. Ismail S,
    5. Rizvi N,
    6. Ghazal S,
    7. et al.

    (2014) Prognostic factors in tuberculosis related mortalities in hospitalized patients. Tuberc Res Treat 2014:624671.

    OpenUrl
16. ↵
    1. Abouzeid MS,
    2. Al Hakeem RF,
    3. Memish ZA

    (2013) Mortality among tuberculosis patients in Saudi Arabia (2001-2010). Ann Saudi Med 33:247–252.

    OpenUrl
17. ↵
    1. Korzeniewska-Koseła M

    (2016) Tuberculosis in Poland in 2014. Przegl Epidemiol 70:261–272.

    OpenUrl
18. ↵
    1. Heunis JC,
    2. Kigozi NG,
    3. Chikobvu P,
    4. Botha S,
    5. van Rensburg HD

    (2017) Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province. BMC Public Health 17:38.

    OpenUrl
19. ↵
    1. Walpola HC,
    2. Siskind V,
    3. Patel AM,
    4. Konstantinos A,
    5. Derhy P

    (2003) Tuberculosis-related deaths in Queensland, Australia 1989-1998: characteristics and risk factors. Int J Tuberc Lung Dis 7:742–750.

    OpenUrlPubMedWeb of Science
20. ↵
    1. Salinas JL,
    2. Armstrong LR,
    3. Silk BJ,
    4. Haddad MB,
    5. Cegielski JP

    (2017) Factors associated with all-cause mortality among patients with multidrug-resistant tuberculosis-United States 1993-2013. Clin Infect Dis 65:1924–1926.

    OpenUrl
21. ↵
    1. El Sahly HM,
    2. Teeter LD,
    3. Pawlak RR,
    4. Musser JM,
    5. Graviss EA

    (2006) Drug-resistant tuberculosis: a disease of target population in Houston, Texas. J Infect 53:5–11.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    1. Field N,
    2. Lim MS,
    3. Murray J,
    4. Dowdeswell RJ,
    5. Glynn JR,
    6. Sonnenberg P

    (2014) Timing, rates, and causes of death in a large South African tuberculosis programme. BMC Infect Dis 14:3858.

    OpenUrl
23. ↵
    1. Sileshi B,
    2. Deyessa N,
    3. Girma B,
    4. Melese M,
    5. Suarez P

    (2013) Predictors of mortality among TB-HIV co-infected patients being treated for tuberculosis in Northwest Ethiopia: a retrospective cohort study. BMC Infect Dis 13:297.

    OpenUrl
24. ↵
    1. Mabunda TE,
    2. Ramalivhana NJ,
    3. Dambisya YM

    (2014) Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa. Afr Health Sci 14:849–854.

    OpenUrl